Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy

We studied mitochondrial respiratory chain function in skeletal muscle taken from 27 patients with idiopathic Parkinson's disease (PD; 21 Dopa-treated PD patients and 6 de novo patients), 5 patients with multiple system atrophy (MSA) and from 43 age-matched controls in order to determine the oc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the neurological sciences 1994-08, Vol.125 (1), p.95-101
Hauptverfasser: Blin, O., Desnuelle, C., Rascol, O., Borg, M., Paul, H.Peyro Saint, Azulay, J.P., Billé, F., Figarella, D., Coulom, F., Pellissier, J.F., Montastruc, J.L., Chatel, M., Serratrice, G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 101
container_issue 1
container_start_page 95
container_title Journal of the neurological sciences
container_volume 125
creator Blin, O.
Desnuelle, C.
Rascol, O.
Borg, M.
Paul, H.Peyro Saint
Azulay, J.P.
Billé, F.
Figarella, D.
Coulom, F.
Pellissier, J.F.
Montastruc, J.L.
Chatel, M.
Serratrice, G.
description We studied mitochondrial respiratory chain function in skeletal muscle taken from 27 patients with idiopathic Parkinson's disease (PD; 21 Dopa-treated PD patients and 6 de novo patients), 5 patients with multiple system atrophy (MSA) and from 43 age-matched controls in order to determine the occurrence of mitochondrial respiratory chain abnormalities in parkinsonian syndromes. In our control subjects, we found a significant age-related decrease in the activity of respiratory chain complex I. As compared to carefully age-matched control subjects, activity of complex (NADH: ubiquinone reductase) was significantly lower in muscle mitochondria from patients with PD and MSA and a mean remaining activity < 30% of controls was observed. Mean activities of complexes III (ubiquinol:cytochrome c reductase) and IV (cytochrome c oxidase) were also lower in PD patients than controls, but a low activity (remaining activity < 30% of controls) was observed in only 5 PD patients for complex I and III or I and IV. No deficit in complex II activity (succinate: ubiquinone reductase) was observed. Our results support the hypothesis of a wide-spread mitochondrial complex I deficiency in PD and MSA as compared to age-matched controls, who showed age-related deficiency. This deficit can be found in de novo PD patients as well as in treated patients. The observed respiratory enzyme chain deficiency could not be explained by the dose and duration of l-Dopa or dopaminergic agonist treatment, the severity of the disease, anxiety or depression since no significant correlation was found between these parameters and enzyme complexes activities.
doi_str_mv 10.1016/0022-510X(94)90248-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76825460</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0022510X94902488</els_id><sourcerecordid>76825460</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-cb21ba9aa29739f286cd161e2bbd8a2caba8ba440e4b8d990369bf25f8c832873</originalsourceid><addsrcrecordid>eNp9kEtv1DAUhS1EVYbCPwDJC8RjEXAcJ7E3SKjiUakVLEBiZ93YNxrTJE59nVbz78kwo1myuovznaOrj7EXpXhfirL5IISURV2K32-NemeEVLrQj9im1K0uaq2rx2xzQp6wp0R_hBCN1uacnbemUdrUG_ZwE3J02zj5FGDgCWkOCXJMO95DGJaEPEycbnHAvObjQm5A3qc48hlywCkTfwh5y39Aug0TxekNcR8IgZDD5NfGkMO8dmhHGUcOOcV5u3vGznoYCJ8f7wX79eXzz8tvxfX3r1eXn64Lp6o2F66TZQcGQJq2Mr3UjfNlU6LsOq9BOuhAd6CUQNVpb4yoGtP1su6105XUbXXBXh925xTvFqRsx0AOhwEmjAvZttGyVo1YQXUAXYpECXs7pzBC2tlS2L1vu5dp9zKtUfafb6vX2svj_tKN6E-lo-A1f3XMgRwMfYLJBTphSoqqNfs3Px4wXF3cB0yW3CrXoQ8JXbY-hv__8RekBZ--</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76825460</pqid></control><display><type>article</type><title>Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Blin, O. ; Desnuelle, C. ; Rascol, O. ; Borg, M. ; Paul, H.Peyro Saint ; Azulay, J.P. ; Billé, F. ; Figarella, D. ; Coulom, F. ; Pellissier, J.F. ; Montastruc, J.L. ; Chatel, M. ; Serratrice, G.</creator><creatorcontrib>Blin, O. ; Desnuelle, C. ; Rascol, O. ; Borg, M. ; Paul, H.Peyro Saint ; Azulay, J.P. ; Billé, F. ; Figarella, D. ; Coulom, F. ; Pellissier, J.F. ; Montastruc, J.L. ; Chatel, M. ; Serratrice, G.</creatorcontrib><description>We studied mitochondrial respiratory chain function in skeletal muscle taken from 27 patients with idiopathic Parkinson's disease (PD; 21 Dopa-treated PD patients and 6 de novo patients), 5 patients with multiple system atrophy (MSA) and from 43 age-matched controls in order to determine the occurrence of mitochondrial respiratory chain abnormalities in parkinsonian syndromes. In our control subjects, we found a significant age-related decrease in the activity of respiratory chain complex I. As compared to carefully age-matched control subjects, activity of complex (NADH: ubiquinone reductase) was significantly lower in muscle mitochondria from patients with PD and MSA and a mean remaining activity &lt; 30% of controls was observed. Mean activities of complexes III (ubiquinol:cytochrome c reductase) and IV (cytochrome c oxidase) were also lower in PD patients than controls, but a low activity (remaining activity &lt; 30% of controls) was observed in only 5 PD patients for complex I and III or I and IV. No deficit in complex II activity (succinate: ubiquinone reductase) was observed. Our results support the hypothesis of a wide-spread mitochondrial complex I deficiency in PD and MSA as compared to age-matched controls, who showed age-related deficiency. This deficit can be found in de novo PD patients as well as in treated patients. The observed respiratory enzyme chain deficiency could not be explained by the dose and duration of l-Dopa or dopaminergic agonist treatment, the severity of the disease, anxiety or depression since no significant correlation was found between these parameters and enzyme complexes activities.</description><identifier>ISSN: 0022-510X</identifier><identifier>EISSN: 1878-5883</identifier><identifier>DOI: 10.1016/0022-510X(94)90248-8</identifier><identifier>PMID: 7964895</identifier><identifier>CODEN: JNSCAG</identifier><language>eng</language><publisher>Shannon: Elsevier B.V</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Atrophy ; Biological and medical sciences ; Brain Diseases - metabolism ; Brain Diseases - pathology ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Electron Transport Complex I ; Electron Transport Complex III - metabolism ; Electron Transport Complex IV - metabolism ; Histocytochemistry ; Humans ; Medical sciences ; Middle Aged ; Mitochondria, Muscle - metabolism ; Mitochondrial respiratory chain ; Muscle, Skeletal - metabolism ; NAD(P)H Dehydrogenase (Quinone) - metabolism ; NADH, NADPH Oxidoreductases - metabolism ; Nerve Degeneration ; Neurology ; Oxygen Consumption ; Parkinson Disease - metabolism ; Parkinson's disease ; Regression Analysis</subject><ispartof>Journal of the neurological sciences, 1994-08, Vol.125 (1), p.95-101</ispartof><rights>1994</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c437t-cb21ba9aa29739f286cd161e2bbd8a2caba8ba440e4b8d990369bf25f8c832873</citedby><cites>FETCH-LOGICAL-c437t-cb21ba9aa29739f286cd161e2bbd8a2caba8ba440e4b8d990369bf25f8c832873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0022-510X(94)90248-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4203797$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7964895$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Blin, O.</creatorcontrib><creatorcontrib>Desnuelle, C.</creatorcontrib><creatorcontrib>Rascol, O.</creatorcontrib><creatorcontrib>Borg, M.</creatorcontrib><creatorcontrib>Paul, H.Peyro Saint</creatorcontrib><creatorcontrib>Azulay, J.P.</creatorcontrib><creatorcontrib>Billé, F.</creatorcontrib><creatorcontrib>Figarella, D.</creatorcontrib><creatorcontrib>Coulom, F.</creatorcontrib><creatorcontrib>Pellissier, J.F.</creatorcontrib><creatorcontrib>Montastruc, J.L.</creatorcontrib><creatorcontrib>Chatel, M.</creatorcontrib><creatorcontrib>Serratrice, G.</creatorcontrib><title>Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy</title><title>Journal of the neurological sciences</title><addtitle>J Neurol Sci</addtitle><description>We studied mitochondrial respiratory chain function in skeletal muscle taken from 27 patients with idiopathic Parkinson's disease (PD; 21 Dopa-treated PD patients and 6 de novo patients), 5 patients with multiple system atrophy (MSA) and from 43 age-matched controls in order to determine the occurrence of mitochondrial respiratory chain abnormalities in parkinsonian syndromes. In our control subjects, we found a significant age-related decrease in the activity of respiratory chain complex I. As compared to carefully age-matched control subjects, activity of complex (NADH: ubiquinone reductase) was significantly lower in muscle mitochondria from patients with PD and MSA and a mean remaining activity &lt; 30% of controls was observed. Mean activities of complexes III (ubiquinol:cytochrome c reductase) and IV (cytochrome c oxidase) were also lower in PD patients than controls, but a low activity (remaining activity &lt; 30% of controls) was observed in only 5 PD patients for complex I and III or I and IV. No deficit in complex II activity (succinate: ubiquinone reductase) was observed. Our results support the hypothesis of a wide-spread mitochondrial complex I deficiency in PD and MSA as compared to age-matched controls, who showed age-related deficiency. This deficit can be found in de novo PD patients as well as in treated patients. The observed respiratory enzyme chain deficiency could not be explained by the dose and duration of l-Dopa or dopaminergic agonist treatment, the severity of the disease, anxiety or depression since no significant correlation was found between these parameters and enzyme complexes activities.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Atrophy</subject><subject>Biological and medical sciences</subject><subject>Brain Diseases - metabolism</subject><subject>Brain Diseases - pathology</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Electron Transport Complex I</subject><subject>Electron Transport Complex III - metabolism</subject><subject>Electron Transport Complex IV - metabolism</subject><subject>Histocytochemistry</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mitochondria, Muscle - metabolism</subject><subject>Mitochondrial respiratory chain</subject><subject>Muscle, Skeletal - metabolism</subject><subject>NAD(P)H Dehydrogenase (Quinone) - metabolism</subject><subject>NADH, NADPH Oxidoreductases - metabolism</subject><subject>Nerve Degeneration</subject><subject>Neurology</subject><subject>Oxygen Consumption</subject><subject>Parkinson Disease - metabolism</subject><subject>Parkinson's disease</subject><subject>Regression Analysis</subject><issn>0022-510X</issn><issn>1878-5883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtv1DAUhS1EVYbCPwDJC8RjEXAcJ7E3SKjiUakVLEBiZ93YNxrTJE59nVbz78kwo1myuovznaOrj7EXpXhfirL5IISURV2K32-NemeEVLrQj9im1K0uaq2rx2xzQp6wp0R_hBCN1uacnbemUdrUG_ZwE3J02zj5FGDgCWkOCXJMO95DGJaEPEycbnHAvObjQm5A3qc48hlywCkTfwh5y39Aug0TxekNcR8IgZDD5NfGkMO8dmhHGUcOOcV5u3vGznoYCJ8f7wX79eXzz8tvxfX3r1eXn64Lp6o2F66TZQcGQJq2Mr3UjfNlU6LsOq9BOuhAd6CUQNVpb4yoGtP1su6105XUbXXBXh925xTvFqRsx0AOhwEmjAvZttGyVo1YQXUAXYpECXs7pzBC2tlS2L1vu5dp9zKtUfafb6vX2svj_tKN6E-lo-A1f3XMgRwMfYLJBTphSoqqNfs3Px4wXF3cB0yW3CrXoQ8JXbY-hv__8RekBZ--</recordid><startdate>19940801</startdate><enddate>19940801</enddate><creator>Blin, O.</creator><creator>Desnuelle, C.</creator><creator>Rascol, O.</creator><creator>Borg, M.</creator><creator>Paul, H.Peyro Saint</creator><creator>Azulay, J.P.</creator><creator>Billé, F.</creator><creator>Figarella, D.</creator><creator>Coulom, F.</creator><creator>Pellissier, J.F.</creator><creator>Montastruc, J.L.</creator><creator>Chatel, M.</creator><creator>Serratrice, G.</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19940801</creationdate><title>Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy</title><author>Blin, O. ; Desnuelle, C. ; Rascol, O. ; Borg, M. ; Paul, H.Peyro Saint ; Azulay, J.P. ; Billé, F. ; Figarella, D. ; Coulom, F. ; Pellissier, J.F. ; Montastruc, J.L. ; Chatel, M. ; Serratrice, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-cb21ba9aa29739f286cd161e2bbd8a2caba8ba440e4b8d990369bf25f8c832873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Atrophy</topic><topic>Biological and medical sciences</topic><topic>Brain Diseases - metabolism</topic><topic>Brain Diseases - pathology</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Electron Transport Complex I</topic><topic>Electron Transport Complex III - metabolism</topic><topic>Electron Transport Complex IV - metabolism</topic><topic>Histocytochemistry</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mitochondria, Muscle - metabolism</topic><topic>Mitochondrial respiratory chain</topic><topic>Muscle, Skeletal - metabolism</topic><topic>NAD(P)H Dehydrogenase (Quinone) - metabolism</topic><topic>NADH, NADPH Oxidoreductases - metabolism</topic><topic>Nerve Degeneration</topic><topic>Neurology</topic><topic>Oxygen Consumption</topic><topic>Parkinson Disease - metabolism</topic><topic>Parkinson's disease</topic><topic>Regression Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blin, O.</creatorcontrib><creatorcontrib>Desnuelle, C.</creatorcontrib><creatorcontrib>Rascol, O.</creatorcontrib><creatorcontrib>Borg, M.</creatorcontrib><creatorcontrib>Paul, H.Peyro Saint</creatorcontrib><creatorcontrib>Azulay, J.P.</creatorcontrib><creatorcontrib>Billé, F.</creatorcontrib><creatorcontrib>Figarella, D.</creatorcontrib><creatorcontrib>Coulom, F.</creatorcontrib><creatorcontrib>Pellissier, J.F.</creatorcontrib><creatorcontrib>Montastruc, J.L.</creatorcontrib><creatorcontrib>Chatel, M.</creatorcontrib><creatorcontrib>Serratrice, G.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blin, O.</au><au>Desnuelle, C.</au><au>Rascol, O.</au><au>Borg, M.</au><au>Paul, H.Peyro Saint</au><au>Azulay, J.P.</au><au>Billé, F.</au><au>Figarella, D.</au><au>Coulom, F.</au><au>Pellissier, J.F.</au><au>Montastruc, J.L.</au><au>Chatel, M.</au><au>Serratrice, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy</atitle><jtitle>Journal of the neurological sciences</jtitle><addtitle>J Neurol Sci</addtitle><date>1994-08-01</date><risdate>1994</risdate><volume>125</volume><issue>1</issue><spage>95</spage><epage>101</epage><pages>95-101</pages><issn>0022-510X</issn><eissn>1878-5883</eissn><coden>JNSCAG</coden><abstract>We studied mitochondrial respiratory chain function in skeletal muscle taken from 27 patients with idiopathic Parkinson's disease (PD; 21 Dopa-treated PD patients and 6 de novo patients), 5 patients with multiple system atrophy (MSA) and from 43 age-matched controls in order to determine the occurrence of mitochondrial respiratory chain abnormalities in parkinsonian syndromes. In our control subjects, we found a significant age-related decrease in the activity of respiratory chain complex I. As compared to carefully age-matched control subjects, activity of complex (NADH: ubiquinone reductase) was significantly lower in muscle mitochondria from patients with PD and MSA and a mean remaining activity &lt; 30% of controls was observed. Mean activities of complexes III (ubiquinol:cytochrome c reductase) and IV (cytochrome c oxidase) were also lower in PD patients than controls, but a low activity (remaining activity &lt; 30% of controls) was observed in only 5 PD patients for complex I and III or I and IV. No deficit in complex II activity (succinate: ubiquinone reductase) was observed. Our results support the hypothesis of a wide-spread mitochondrial complex I deficiency in PD and MSA as compared to age-matched controls, who showed age-related deficiency. This deficit can be found in de novo PD patients as well as in treated patients. The observed respiratory enzyme chain deficiency could not be explained by the dose and duration of l-Dopa or dopaminergic agonist treatment, the severity of the disease, anxiety or depression since no significant correlation was found between these parameters and enzyme complexes activities.</abstract><cop>Shannon</cop><pub>Elsevier B.V</pub><pmid>7964895</pmid><doi>10.1016/0022-510X(94)90248-8</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-510X
ispartof Journal of the neurological sciences, 1994-08, Vol.125 (1), p.95-101
issn 0022-510X
1878-5883
language eng
recordid cdi_proquest_miscellaneous_76825460
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adult
Aged
Aged, 80 and over
Atrophy
Biological and medical sciences
Brain Diseases - metabolism
Brain Diseases - pathology
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Electron Transport Complex I
Electron Transport Complex III - metabolism
Electron Transport Complex IV - metabolism
Histocytochemistry
Humans
Medical sciences
Middle Aged
Mitochondria, Muscle - metabolism
Mitochondrial respiratory chain
Muscle, Skeletal - metabolism
NAD(P)H Dehydrogenase (Quinone) - metabolism
NADH, NADPH Oxidoreductases - metabolism
Nerve Degeneration
Neurology
Oxygen Consumption
Parkinson Disease - metabolism
Parkinson's disease
Regression Analysis
title Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T09%3A43%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mitochondrial%20respiratory%20failure%20in%20skeletal%20muscle%20from%20patients%20with%20Parkinson's%20disease%20and%20multiple%20system%20atrophy&rft.jtitle=Journal%20of%20the%20neurological%20sciences&rft.au=Blin,%20O.&rft.date=1994-08-01&rft.volume=125&rft.issue=1&rft.spage=95&rft.epage=101&rft.pages=95-101&rft.issn=0022-510X&rft.eissn=1878-5883&rft.coden=JNSCAG&rft_id=info:doi/10.1016/0022-510X(94)90248-8&rft_dat=%3Cproquest_cross%3E76825460%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76825460&rft_id=info:pmid/7964895&rft_els_id=0022510X94902488&rfr_iscdi=true